Regulatory Due Diligence

Regulatory due diligence is the process of assessing the compliance status, regulatory risks, quality systems, and documentation maturity of medical devices or healthcare technologies before investment, acquisition, licensing, or partnership decisions.

Reviews may include technical documentation, device classification, quality management systems, software lifecycle processes, cybersecurity, clinical evidence, post-market activities, regulatory submissions, and ongoing compliance obligations.

Yes. MedQAIR supports due diligence activities for software medical devices, AI-enabled systems, digital health platforms, medical devices, and IVDs across MDR, IVDR, FDA, and related regulatory frameworks.

Regulatory gaps or unresolved compliance issues can significantly affect product timelines, market access, operational costs, and long-term business value. Due diligence helps organisations identify potential risks and remediation needs before major decisions are finalised.

(Existing FAQ from MedQAIR FAQ page — relevant to this service page)

Yes. MedQAIR supports regulatory submissions for the US (FDA), Canada (Health Canada), and other global markets. This includes preparing 510(k), De Novo, PMA, and Canadian licensing documentation, as well as aligning technical files for multi-market compliance.

Common findings include incomplete technical documentation, unclear device classification, unresolved nonconformities, inadequate clinical evidence, software lifecycle gaps, cybersecurity deficiencies, missing post-market documentation, and quality management system weaknesses. Identifying these issues early helps organisations understand potential remediation efforts and associated business risks.

A quality management system audit focuses on compliance with defined quality requirements and procedures. Regulatory due diligence takes a broader view by evaluating technical documentation, regulatory status, market access risks, software compliance, clinical evidence, cybersecurity considerations, and overall regulatory readiness in the context of business decisions.

Technical documentation provides evidence that a product has been developed, validated, and maintained in accordance with applicable regulatory requirements. Reviewing technical files helps identify documentation gaps, unsupported claims, missing evidence, or compliance risks that could affect market access, product valuation, or future regulatory activities.

Yes. AI-enabled products may be assessed for issues relating to governance structures, data management practices, software lifecycle controls, transparency requirements, cybersecurity considerations, and compliance with applicable AI-related regulations and standards. Early identification of these risks can support more informed investment and acquisition decisions.

Reviews typically assess software development procedures, change management activities, verification and validation records, traceability, maintenance processes, cybersecurity controls, and supporting documentation. The objective is to determine whether lifecycle activities support ongoing regulatory compliance and product maintenance obligations.

Following identification of gaps, organisations can prioritise remediation activities based on risk, business objectives, regulatory impact, and available resources. Remediation planning may include documentation updates, process improvements, additional testing, quality system enhancements, or regulatory strategy adjustments.

Yes. Regulatory due diligence can provide independent insight into the compliance status, regulatory maturity, and potential liabilities associated with products or organisations involved in licensing agreements, strategic partnerships, distribution arrangements, or technology transfers.

MedQAIR supports regulatory due diligence through compliance assessments, technical documentation reviews, quality management system evaluations, software and AI compliance assessments, cybersecurity reviews, regulatory gap analyses, and remediation planning. Our assessments help organisations understand regulatory readiness and potential compliance risks before critical business decisions are made.